ZA200107983B - New compounds, their preparation and use. - Google Patents

New compounds, their preparation and use.

Info

Publication number
ZA200107983B
ZA200107983B ZA200107983A ZA200107983A ZA200107983B ZA 200107983 B ZA200107983 B ZA 200107983B ZA 200107983 A ZA200107983 A ZA 200107983A ZA 200107983 A ZA200107983 A ZA 200107983A ZA 200107983 B ZA200107983 B ZA 200107983B
Authority
ZA
South Africa
Prior art keywords
preparation
new compounds
compounds
new
Prior art date
Application number
ZA200107983A
Inventor
Anthony Murray
Per Sauerberg
Lone Jeppesen
Ingrid Pettersson
Paul Stanley Bury
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA200107983B publication Critical patent/ZA200107983B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
ZA200107983A 1999-04-20 2001-09-28 New compounds, their preparation and use. ZA200107983B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900533 1999-04-20

Publications (1)

Publication Number Publication Date
ZA200107983B true ZA200107983B (en) 2002-05-29

Family

ID=8094620

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107983A ZA200107983B (en) 1999-04-20 2001-09-28 New compounds, their preparation and use.

Country Status (16)

Country Link
EP (1) EP1171414A1 (en)
JP (1) JP2002542218A (en)
KR (1) KR20020005703A (en)
CN (1) CN1348439A (en)
AU (1) AU3958000A (en)
BR (1) BR0009864A (en)
CA (1) CA2367356A1 (en)
CZ (1) CZ20013558A3 (en)
HU (1) HUP0200807A3 (en)
IL (1) IL145789A0 (en)
NO (1) NO20015113L (en)
PL (1) PL351312A1 (en)
RU (1) RU2001131111A (en)
TW (1) TW553931B (en)
WO (1) WO2000063153A1 (en)
ZA (1) ZA200107983B (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555577B1 (en) 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
JP2003520838A (en) * 2000-01-28 2003-07-08 ノボ ノルディスク アクティーゼルスカブ New compounds, their manufacture and use.
JP2003525908A (en) 2000-03-08 2003-09-02 ノボ ノルディスク アクティーゼルスカブ Low serum lipids
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
US6869967B2 (en) 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
US7067530B2 (en) 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
JP2004536150A (en) * 2001-07-30 2004-12-02 ノボ　ノルディスク　アクティーゼルスカブ Novel vinyl, carboxylic acid derivatives and their use as antibiotics etc.
JP2004536152A (en) * 2001-07-30 2004-12-02 ノボ　ノルディスク　アクティーゼルスカブ Novel vinyl N- (2-benzoylphenyl) -L-tyrosine derivatives and their use for antidiabetic agents and the like
EP1414806A1 (en) * 2001-07-30 2004-05-06 Novo Nordisk A/S Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
JP4563675B2 (en) 2001-10-12 2010-10-13 ハイ・ポイント・ファーマスーティカルズ、エルエルシー Substituted piperidines and their use for the treatment of histamine H3 receptor related diseases
BR0215212A (en) 2001-12-21 2004-12-07 Novo Nordisk As Carboxamide or glycoside sulfonamide activator, compound, pharmaceutical composition, and use of a compound
US7015345B2 (en) 2002-02-21 2006-03-21 Asahi Kasei Pharma Corporation Propionic acid derivatives
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
KR101116627B1 (en) 2002-06-27 2012-10-09 노보 노르디스크 에이/에스 Aryl carbonyl derivatives as therapeutic agents
PL375700A1 (en) * 2002-09-05 2005-12-12 Novo Nordisk A/S Novel vinyl carboxylic acid derivatives and their therapeutical use
US7129268B2 (en) * 2002-10-28 2006-10-31 Novo Nordisk A/S Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
KR20050055790A (en) * 2002-10-28 2005-06-13 노보 노르디스크 에이/에스 Novel compounds useful in treating ppar mediated diseases
CN100491316C (en) 2002-10-28 2009-05-27 高点制药有限责任公司 Novel compounds, their preparation and use
EP1558572B1 (en) * 2002-10-28 2010-06-30 High Point Pharmaceuticals, LLC Novel compounds and their use as prar-modulators
US7816385B2 (en) 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
EP1578716A1 (en) * 2002-12-20 2005-09-28 Novo Nordisk A/S Dicarboxylic acid derivatives as ppar-agonists
DE602004022153D1 (en) 2003-05-14 2009-09-03 High Point Pharmaceuticals Llc COMPOUNDS FOR THE TREATMENT OF OBESITAS
DE602004022179D1 (en) 2003-09-19 2009-09-03 Janssen Pharmaceutica Nv 4 - ((PHENOXYALKYL) THIO) -PHENOXY ACETIC ACIDS AND ANALOGUES
MXPA06003474A (en) 2003-09-30 2006-06-05 Novo Nordisk As Melanocortin receptor agonists.
EP1694356B1 (en) 2003-12-09 2011-02-16 Novo Nordisk A/S Regulation of food preference using glp-1 agonists
DK1723128T3 (en) 2004-01-06 2013-02-18 Novo Nordisk As Heteroarlurines and their use as glucokinase activators
JP2007536344A (en) 2004-05-04 2007-12-13 ノボ　ノルディスク　アクティーゼルスカブ New indole derivatives
WO2005105725A1 (en) * 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
ATE515494T1 (en) 2004-05-05 2011-07-15 High Point Pharmaceuticals Llc NEW COMPOUNDS, THEIR PRODUCTION AND USE
CN1950078A (en) 2004-06-11 2007-04-18 诺和诺德公司 Counteracting drug-induced obesity using glp-1 agonists
JP4874989B2 (en) 2004-11-22 2012-02-15 ノヴォ ノルディスク アー／エス Soluble and stable insulin-containing formulation
CA2590720A1 (en) 2004-12-03 2006-06-08 Lone Jeppesen Heteroaromatic glucokinase activators
FR2882359A1 (en) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S New phenyl compounds are peroxisome proliferator activated receptor activators useful to treat hyperlipidemia and atherosclerosis
WO2006091047A1 (en) * 2005-02-25 2006-08-31 Heonjoong Kang Thiazole derivatives as ppar delta ligands and their manufacturing process
AU2006264966B2 (en) 2005-07-04 2013-02-21 High Point Pharmaceuticals, Llc Histamine H3 receptor antagonists
JP4960355B2 (en) 2005-07-14 2012-06-27 ノボ・ノルデイスク・エー／エス Urea-type glucokinase activator
ES2426345T3 (en) 2005-07-20 2013-10-22 Eli Lilly And Company Compound bound in 1-amino position
PL1951658T3 (en) 2005-11-17 2013-02-28 Lilly Co Eli Glucagon receptor antagonists, preparation and therapeutic uses
EP2386540A1 (en) 2005-12-22 2011-11-16 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
KR101280333B1 (en) 2006-03-28 2013-07-02 하이 포인트 파마슈티칼스, 엘엘씨 Benzothiazoles having histamine ｈ３ receptor activity
CA2659570C (en) 2006-05-29 2015-10-06 High Point Pharmaceuticals, Llc 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
ES2377322T3 (en) 2006-11-15 2012-03-26 High Point Pharmaceuticals, Llc New 2- (2-hydroxyphenyl) benzothiadiazines useful for the treatment of obesity and diabetes
ATE523497T1 (en) 2006-11-15 2011-09-15 High Point Pharmaceuticals Llc NEW 2-(2-HYDROXYPHENYL)BENZIMIDAZOLES SUITABLE FOR THE TREATMENT OF OBESITAS AND DIABETES
AU2008204530B2 (en) 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
US20130012432A1 (en) 2010-02-26 2013-01-10 Novo Nordisk A/S Peptides for Treatment of Obesity
BR112012021231A2 (en) 2010-02-26 2015-09-08 Basf Plant Science Co Gmbh method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product
RU2559320C2 (en) 2010-03-26 2015-08-10 Ново Нордиск А/С Novel glucagon analogues
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
EP2670368A4 (en) 2011-02-03 2015-04-15 Pharmedica Ltd New oral dissolving films for insulin administration, for treating diabetes
AU2012234276A1 (en) 2011-03-28 2013-08-29 Novo Nordisk A/S Novel glucagon analogues
TWI596110B (en) 2011-09-23 2017-08-21 諾佛 儂迪克股份有限公司 Novel glucagon analogues
WO2014170496A1 (en) 2013-04-18 2014-10-23 Novo Nordisk A/S Stable, protracted glp-1/glucagon receptor co-agonists for medical use
CN106536547A (en) 2014-06-04 2017-03-22 诺和诺德股份有限公司 GLP-1/glucagon receptor co-agonists for medical use
CN107915701B (en) * 2016-10-10 2020-09-29 沈阳药科大学 PPAR alpha/gamma dual agonist and application thereof
CN111032680A (en) 2017-03-15 2020-04-17 诺和诺德股份有限公司 Bicyclic compounds capable of binding to melanocortin 4 receptor
WO2019219714A1 (en) 2018-05-15 2019-11-21 Novo Nordisk A/S Compounds capable of binding to melanocortin 4 receptor
WO2020053414A1 (en) 2018-09-14 2020-03-19 Novo Nordisk A/S Bicyclic compounds capable of acting as melanocortin 4 receptor agonists
CA3185909A1 (en) 2020-07-22 2022-01-27 Reneo Pharmaceuticals, Inc. Crystalline ppar-delta agonist
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004261A1 (en) * 1994-07-29 1996-02-15 Smithkline Beecham Plc Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE69815008T2 (en) * 1997-09-19 2004-04-01 Ssp Co., Ltd. Alpha-substituted phenylpropionic acid derivatives and medicaments containing them
WO1999020614A1 (en) * 1998-05-27 1999-04-29 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) * 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
CN1280574A (en) * 1997-10-27 2001-01-17 雷迪研究基金会 New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them
AU1887999A (en) * 1998-01-29 1999-08-16 Dr. Reddy's Research Foundation Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
AU1120599A (en) * 1998-04-23 1999-03-08 Dr. Reddy's Research Foundation New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2367356A1 (en) 2000-10-26
CN1348439A (en) 2002-05-08
NO20015113D0 (en) 2001-10-19
WO2000063153A1 (en) 2000-10-26
KR20020005703A (en) 2002-01-17
EP1171414A1 (en) 2002-01-16
PL351312A1 (en) 2003-04-07
JP2002542218A (en) 2002-12-10
IL145789A0 (en) 2002-07-25
AU3958000A (en) 2000-11-02
BR0009864A (en) 2002-01-08
TW553931B (en) 2003-09-21
HUP0200807A3 (en) 2003-03-28
CZ20013558A3 (en) 2002-05-15
HUP0200807A2 (en) 2002-07-29
NO20015113L (en) 2001-12-19
RU2001131111A (en) 2003-08-10

Similar Documents

Publication Publication Date Title
ZA200107983B (en) New compounds, their preparation and use.
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
AU3957900A (en) New compounds, their preparation and use
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
AU6325599A (en) New compounds, their preparation and use
AU6325899A (en) New compounds, their preparation and use
AU6190199A (en) New compounds, their preparation and use
AU6325799A (en) New compounds, their preparation and use
HK1048999A1 (en) Azepinoindole derivatives, their preparation and use thereof
AU6190299A (en) New compounds, their preparation and use
AU6325699A (en) New compounds, their preparation and use
AU2001248279A1 (en) New compounds, their preparation and use
HK1034722A1 (en) Antipicornaviral compounds, their preparation and use
HK1051199A1 (en) New phenylpiperazines.
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
ZA996814B (en) Aluminosilicate compositions, preparation and use.
ZA200200222B (en) Titanium derived compounds, preparation and use thereof.
EP1210084A4 (en) Pyridomorphinans, thienomoprhinans and use thereof
AU3595099A (en) New compounds, their preparation and use
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA200109571B (en) Novel compounds, their use and preparation.
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.